The Rehabilitation Engineering Lab (RELab) at the Department of Health Sciences and Technology at ETH Zurich is an interdisciplinary group with competencies in mechanical and electrical engineering, movement science, neurorehabilitation and neuroscience. The RELab uses robotics, wearable sensor technologies, and non-invasive neuroimaging to explore, assess and restore sensorimotor function in persons with neurological injury, to promote sensorimotor recovery and independence.
Together with the Cereneo Center for Neurology and Neurorehabilitation we are developing a novel, neuroimaging-guided therapy method to support point-of-care treatments in stroke rehabilitation, aiming to seamlessly include the brain in the neurorehabilitation therapy.
Stroke is a leading cause of long-term disability worldwide, with a strongly increasing prevalence that leaves two thirds of patients with long-term upper-limb impairments, impacting their independence and quality of life. Neurorehabilitation in stroke is a complex field, challenged by a limited understanding of the neural mechanisms underlying recovery as well as the lack of effective strategies to target these mechanisms and efficient biomarkers to evaluate and monitor therapy response.
We aim to address these challenges by combining non-invasive brain stimulation (NIBS) using transcranial magnetic stimulation (TMS) and a cortical, focal optical imaging approach using near-infrared imaging (NIRI). Our goal is to combine these two promising technologies and transfer them into a clinically viable solution to provide neurotherapy to stroke patients. The utilization of biomarker-guided assessments for novel interventions aligns with the contemporary paradigm shift towards personalized medicine in stroke research and clinical practice.
In the framework of a Bridge Discovery project, we are searching for a suitable candidate that drives the personalization of stroke treatment through the combination of repeated TMS (rTMS) with NIRI to actively target the underlying brain mechanisms involved in stroke recovery. In this position, the candidate will focus on the implementation and validation of this approach in a clinical setting. In particular, you will be responsible for developing a clinically viable rTMS neurotherapy approach that is assessed by NIRI. You will set up the study, validate it on healthy subjects and stroke patients, and analyze the data. Your task will be to correlate biomarkers derived from rTMS and NIRI with clinical outcomes, in order to personalize stroke rehabilitation and improve the recovery process. Statistical analyses will be performed as well as topological plots of brain recovery.
We look forward to receiving your online application with the following documents:
We are looking for a candidate that can start as soon as possible.
Please note that we exclusively accept applications submitted through our online application portal. Applications via email or postal services will not be considered.
Further information about the Rehabilitation Engineering Laboratory (RELab) can be found on our website. Questions regarding the position should be directed to Dr. Dominik Wyser, dominik.wyser@hest.ethz.ch (no applications).
ETH Zürich is well known for its excellent education, ground-breaking fundamental research and for implementing its results directly into practice.
Visit the employer page